Variant report

Variant	rs57138434
Chromosome Location	chr6:27263348-27263349
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:20)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:20 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:27261990..27263611-chr6:27441334..27443428,2	K562	blood:
2	chr6:27261653..27264204-chr6:27341617..27343820,2	K562	blood:
3	chr6:27261806..27264755-chr6:27859413..27861745,2	K562	blood:
4	chr6:27260766..27263711-chr6:27659606..27661608,2	K562	blood:
5	chr6:27263089..27265493-chr6:27438139..27440840,3	MCF-7	breast:
6	chr6:27097893..27101461-chr6:27263240..27264846,3	K562	blood:
7	chr6:27219267..27221635-chr6:27262171..27265020,3	K562	blood:
8	chr6:27180877..27182881-chr6:27262753..27266056,3	K562	blood:
9	chr6:27218297..27220785-chr6:27262344..27265020,2	K562	blood:
10	chr6:27260999..27263500-chr6:27265988..27267831,3	K562	blood:
11	chr6:27263338..27266126-chr6:27718637..27721483,2	K562	blood:
12	chr6:27255029..27257456-chr6:27262507..27264289,2	MCF-7	breast:
13	chr6:27254367..27256212-chr6:27263059..27265882,2	MCF-7	breast:
14	chr6:27116381..27118425-chr6:27261911..27264171,2	K562	blood:
15	chr6:27197041..27202373-chr6:27261458..27267425,7	K562	blood:
16	chr6:27261110..27263869-chr6:27440100..27444366,4	K562	blood:
17	chr6:27262330..27264270-chr6:27461597..27464387,2	K562	blood:
18	chr6:27246057..27248417-chr6:27262936..27265446,2	MCF-7	breast:
19	chr6:27262603..27264877-chr6:27278498..27281369,2	K562	blood:
20	chr6:27261602..27264204-chr6:27341617..27343393,2	K562	blood:

No data

Variant related genes	Relation type
ENSG00000196331	Chromatin interaction
ENSG00000197153	Chromatin interaction
ENSG00000124613	Chromatin interaction
ENSG00000233224	Chromatin interaction
ENSG00000124635	Chromatin interaction
ENSG00000196787	Chromatin interaction
ENSG00000158553	Chromatin interaction
ENSG00000112812	Chromatin interaction
ENSG00000096654	Chromatin interaction

Extended variants
information (count: 16 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:13)

rs_ID	r²[population]
rs3734576	1.00[AMR][1000 genomes];1.00[ASN][1000 genomes]
rs3800315	0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[ASN][1000 genomes]
rs56816292	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[ASN][1000 genomes]
rs73384398	0.80[ASN][1000 genomes]
rs73386688	0.93[ASN][1000 genomes]
rs73388520	0.85[AMR][1000 genomes];0.93[ASN][1000 genomes]
rs73390650	1.00[AMR][1000 genomes];1.00[ASN][1000 genomes]
rs9461343	0.85[AMR][1000 genomes];1.00[ASN][1000 genomes]
rs9461345	1.00[AMR][1000 genomes]
rs9468019	0.85[AMR][1000 genomes];1.00[ASN][1000 genomes]
rs9468031	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[ASN][1000 genomes]
rs9468034	0.91[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[ASN][1000 genomes]
rs9468058	0.81[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:3 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv948921	chr6:26556890-27443957	Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	472 gene(s)	inside rSNPs	diseases
2	nsv1017328	chr6:27177147-27369588	Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription ZNF genes & repeats Strong transcription Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	29 gene(s)	inside rSNPs	diseases
3	nsv883505	chr6:27210614-27300580	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers ZNF genes & repeats Strong transcription Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	23 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:39 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:27259400-27263400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
2	chr6:27259400-27263600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
3	chr6:27261000-27263800	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
4	chr6:27261000-27264600	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
5	chr6:27261000-27264600	ZNF genes & repeats	Primary hematopoietic stem cells short term culture	blood
6	chr6:27261000-27265600	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
7	chr6:27261000-27266400	Active TSS	ES-I3 Cell Line	embryonic stem cell
8	chr6:27261000-27266400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
9	chr6:27261000-27266800	Active TSS	A549	lung
10	chr6:27261200-27263400	ZNF genes & repeats	GM12878-XiMat	blood
11	chr6:27261200-27263600	Active TSS	HUES48 Cell Line	embryonic stem cell
12	chr6:27261400-27266400	Active TSS	H9 Cell Line	embryonic stem cell
13	chr6:27261400-27266400	Active TSS	HUES6 Cell Line	embryonic stem cell
14	chr6:27261400-27266400	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
15	chr6:27261600-27263400	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
16	chr6:27261600-27263400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
17	chr6:27261600-27264600	Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
18	chr6:27262200-27263800	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
19	chr6:27262200-27264000	Flanking Active TSS	K562	blood
20	chr6:27262200-27264000	Flanking Active TSS	NHEK	skin
21	chr6:27262200-27264200	Flanking Bivalent TSS/Enh	HepG2	liver
22	chr6:27262600-27266400	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
23	chr6:27262800-27264000	Flanking Active TSS	Hela-S3	cervix
24	chr6:27262800-27264000	Flanking Active TSS	HMEC	breast
25	chr6:27262800-27266000	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
26	chr6:27263000-27263400	Enhancers	Osteobl	bone
27	chr6:27263000-27263600	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
28	chr6:27263000-27264200	Bivalent/Poised TSS	Primary T cells from cord blood	blood
29	chr6:27263000-27266400	Active TSS	H1 Cell Line	embryonic stem cell
30	chr6:27263200-27263400	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
31	chr6:27263200-27263400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
32	chr6:27263200-27263400	Bivalent/Poised TSS	HUVEC	blood vessel
33	chr6:27263200-27263600	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
34	chr6:27263200-27264200	Bivalent/Poised TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
35	chr6:27263200-27264800	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
36	chr6:27263200-27264800	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
37	chr6:27263200-27265400	Active TSS	HSMMtube	muscle
38	chr6:27263200-27265800	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
39	chr6:27263200-27266000	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links